Insight of pancreatic cancer: recommendations for improving its therapeutic efficacy in the next decade

被引:9
|
作者
Xu, Zhi-Hang [1 ,2 ]
Wang, Wen-Quan [1 ,2 ]
Lou, Wen-Hui [1 ,2 ,3 ]
Liu, Liang [1 ,2 ,3 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Pancreat Surg, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Pancreat Surg, 180 Feng Lin Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Chinese medicine; Diagnosis; Model; Pancreatic cancer; Prevention; Review; Therapy; ANTIBODY-DRUG CONJUGATE; DUCTAL ADENOCARCINOMA; ENHANCED RECOVERY; DISTINCT TUMOR; HIGH-RISK; SURGERY; PANCREATICODUODENECTOMY; DIAGNOSIS; SUBTYPES; SURVIVAL;
D O I
10.1097/JP9.0000000000000093
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pancreatic cancer is one of the most malignant digestive system tumors. The effectiveness of pancreatic cancer treatment is still dismal, and the 5-year survival rate is only about 10%. Further improving the diagnosis and treatment of pancreatic cancer is the top priority of oncology research and clinical practice. Based on the existing clinical and scientific research experience, the review provides insight into the hotspots and future directions for pancreatic cancer, which focuses on early detection, early diagnosis, molecular typing and precise treatment, new drug development and regimen combination, immunotherapy, database development, model establishment, surgical technology and strategy change, as well as innovation of traditional Chinese medicine and breakthrough of treatment concept.
引用
收藏
页码:58 / 68
页数:11
相关论文
共 50 条
  • [31] A Pharmacological Insight of Piperlongumine, Bioactive Validating Its Therapeutic Efficacy as a Drug to Treat Inflammatory Diseases
    Zhao, M.
    Wang, X.
    Kumar, S. A.
    Yao, Y.
    Sun, M.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2023, 49 (02) : 236 - 248
  • [32] A Pharmacological Insight of Piperlongumine, Bioactive Validating Its Therapeutic Efficacy as a Drug to Treat Inflammatory Diseases
    M. Zhao
    X. Wang
    S. A. Kumar
    Y. Yao
    M. Sun
    Russian Journal of Bioorganic Chemistry, 2023, 49 : 236 - 248
  • [33] BECLOMETHASONE DIPROPIONATE - A REAPPRAISAL OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY AFTER A DECADE OF USE IN ASTHMA AND RHINITIS
    BROGDEN, RN
    HEEL, RC
    SPEIGHT, TM
    AVERY, GS
    DRUGS, 1984, 28 (02) : 99 - 126
  • [34] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Stalnecker, Clint A.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Pieper, Noah L.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2023, 83 (07)
  • [35] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Roach, Mallory K.
    Pieper, Noah L.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Stalnecker, Clint A.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2024, 84 (02)
  • [36] Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients
    Gillson, Josef E.
    Byeon, Sooin
    Chou, Angela
    Maloney, Sarah
    Pavlakis, Nick
    Clarke, Stephen J.
    Chan, David L.
    Diakos, Connie I.
    Gill, Anthony J.
    Samra, Jaswinder S.
    Mittal, Anubhav
    Sahni, Sumit
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2025, 55 (02)
  • [37] CYPROTERONE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY IN PROSTATE-CANCER
    BARRADELL, LB
    FAULDS, D
    DRUGS & AGING, 1994, 5 (01) : 59 - 80
  • [38] Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy
    Alshammari, Mohammed Kanan
    Alghazwni, Mohammed Khalid
    Alharbi, Abrar Saleh
    Alqurashi, Ghayda Ghazi
    Kamal, Mehnaz
    Alnufaie, Salman Rahim
    Alshammari, Salem Sayer
    Alshehri, Bandar Ali
    Tayeb, Rami Hatem
    Bougeis, Rashad Jameel M.
    Aljehani, Alaa Adel
    Alotaibi, Nawaf M. M.
    Abida, Abida
    Imran, Mohd
    CANCERS, 2023, 15 (01)
  • [39] New Insight in Improving Therapeutic Efficacy of Antipsychotic Agents: An Overview of Improved in vitro and in vivo Performance, Efficacy Up-gradation and Future Prospects
    Thu, Hnin Ei
    Hussain, Zahid
    Shuid, Ahmad Nazrun
    CURRENT DRUG TARGETS, 2018, 19 (08) : 865 - 876
  • [40] Improving the targeting and therapeutic efficacy of anastrazole for the control of breast cancer: In vitro and in vivo characterization
    El-Bakry, Rana
    Mahmoud, Dina M.
    Attia, Mary Eskander
    Fouad, Amr Gamal
    Mohammed, Nada H.
    Belal, Amany
    Miski, Samar F.
    Albezrah, Nisreen Khalid Aref
    Abduljabbar, Maram H.
    Mahmoud, Tamer M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 665